 |
|
|
| |
Reasons for Treatment Discontinuation Among Hepatitis C Patients Treated in Clinical Practice
|
| |
| |
Reported by Jules Levin
APASL 2013 Singapore June 6-10
Ulcickas Yood MU,1 Sapra S,2 Oliveria SA,1 Casso D,1 Fu A-C,3 L'Italien GJ2
1EpiSource, LLC, Newton, MA; 2Bristol-Myers Squibb, Plainsboro, NJ; 3HealthCore, Wilmington, DE
BACKGROUND
Previous investigation has indicated low viral suppression in patients who discontinue treatment with peginterferon alfa-2a or alfa-2b (alfa) and ribavirin (RBV) for chronic hepatitis C
The objective of the current analysis was to investigate reasons for treatment discontinuation in a clinical setting of patients treated with alfa/RBV, which either together or with newly approved antivirals is the current treatment for hepatitis C
|
| |
|
|
|
|
|
